From worth $4.5 billion to losing everything: "The goddess of blood test" is dead like this
The Wall Street Journal recently wrote an article about how Theranos strictly controls the flow of information, making it possible for people inside and outside the company to look at the flowers and to distinguish between true and false. The article said that company founder and CEO Elizabeth Holmes gave a speech to employees last month. Participants said she used a slide show to show the company's blood test technology: only a small amount of blood needs to be collected, and 304 tests can be performed. But one thing she didn't say was that most of these tests were conducted in the lab of the lab. The company has been caught in a deep scandal, and the 32-year-old Holmes continues to whitewash it – she has hidden her employees on many issues, even though the company has been involved in regulatory and legal disputes. The SEC and the San Francisco Prosecutor's Office are investigating Theranos to see if it misleads investors and regulators in terms of technology and operations. After the regulator imposed a penalty on Theranos, the company said in a statement: "We accept all responsibility related to our problem at our Newark laboratory in California, and we are taking comprehensive remedies (such as Shut down the lab, etc.), "The company said it would fully cooperate with the investigation. Sharp decline in trust In the internal speech last month, everyone noticed the details she did not disclose, which further reduced the trust between Holmes and employees. Theranos has acknowledged to the federal health regulatory structure that its proprietary "Edison" blood test instrument can only perform 12 tests on blood samples and will stop using it in June 2015. The document shows that Theranos offers more than 200 testing services for consumers, from prostate cancer to cholesterol testing, in commercial laboratory equipment. Until recently, many of Theranos employees have been willing to believe in Homs. But in May, their loyalty began to decline sharply, because the Wall Street Journal reported in May that Theranos announced the abolition of the test report of the "Edison" blood test instrument in the past two years (because of the detection bias). Theranos made the decision and reported it to the regulator for more than a month before letting employees know about it. A spokesperson for Theranos said the company would not comment on internal staff meetings. “The employees of Theranos have the talent, dedication and leadership and are the soul of the company, committed to providing customers with actionable, affordable health care information,†she said.
Xi'an Henrikang Biotech Co., Ltd., is a professional supplier of Antipyretic And Analgesic ; APIs Raw powder ; Antibiotic & Antibacterial ; Blood Pressure raw powder, and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.
If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.
Active Ingredients Gabapentin Powder,Piroctone Olamine Powder,Active Ingredients Azithromycin Powder,Active Ingredients Iodixanol Powder Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.
For customer`s needs, OEM service is also acceptable.